Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,628
Closed -$583K 66
2023
Q2
$583K Hold
2,628
0.38% 28
2023
Q1
$635K Hold
2,628
0.49% 26
2022
Q4
$690K Sell
2,628
-6
-0.2% -$1.61K 0.58% 24
2022
Q3
$594K Hold
2,634
0.57% 26
2022
Q2
$641K Hold
2,634
0.6% 25
2022
Q1
$637K Hold
2,634
0.5% 29
2021
Q4
$593K Hold
2,634
0.43% 35
2021
Q3
$557K Buy
2,634
+6
+0.2% +$1.38K 0.47% 29
2021
Q2
$641K Hold
2,628
0.53% 27
2021
Q1
$655K Hold
2,628
0.61% 24
2020
Q4
$660K Buy
+2,628
New +$606K 0.66% 24

Other funds holding AMGN

Montis Financial's AMGN Position: Q3 2023 in Review

Montis Financial sold out of Amgen (AMGN) in Q3 2023, closing a stake of 2,628 shares — an estimated $583K sold.

Montis Financial first reported a position in AMGN in Q4 2020 and held it in 11 quarters. The position peaked at $690K in Q4 2022. 2,501 funds tracked by Wall St. Rank hold AMGN as of Q3 2023.

  • Montis Financial reported no remaining Amgen position as of Q3 2023 after selling out during the quarter.
  • Montis Financial sold 2,628 Amgen shares in Q3 2023, an estimated $583K.
  • Montis Financial first reported a position in Amgen in Q4 2020 and held it in 11 quarters.
  • Montis Financial's Amgen position peaked at $690K in Q4 2022.
  • 2,501 funds tracked by Wall St. Rank held Amgen as of Q3 2023.

Based on Montis Financial's 13F filing for Q3 2023, filed 31 Oct 2023.